Literature DB >> 25034374

A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection.

Maja Sočan1, Katarina Prosenc2, Veronika Učakar3, Nataša Berginc4.   

Abstract

BACKGROUND: The evolution of influenza viruses is characterized by the co-circulation of two antigenically and genetically distinct lineages B/Victoria/2/87-like viruses (Victoria) and B/Yamagata/16/88-like viruses (Yamagata). To date, there is not much data associating lineages variation with demographic and clinical data.
OBJECTIVES: We compared the demographic and clinical characteristics of patients with laboratory-confirmed influenza B Victoria or Yamagata lineage infection. STUDY
DESIGN: We retrospectively analyzed data from 6811 patients aged from <1 through 99 years with influenza like-illness who consulted the sentinel site or sentinel hospital in the seasons 2010/2011, 2011/2012 and 2012/2013. There were 662 patients positive for influenza B virus by multiplex real-time RT-PCR. Six hundred thirty-seven (96.8%) were successfully subtyped for Victoria or Yamagata lineage infection. The available demographic and clinical data was compared.
RESULTS: Patients with the Victoria lineage were significantly younger compared to patients infected with the Yamagata lineage. The Victoria lineage was the predominant strain in the 15-34 age groups in patients consulting at primary care level and in hospitalized patients. In the youngest age group (0-4 years) approximately half of the confirmed influenza B cases belonged to the Victoria (55%) and the rest to the Yamagata lineage (45%). Aside from age, there was no statistically significant difference found in gender distribution, vaccination history, clinical presentation or risk factors for severe influenza infection in hospitalized patients after adjustment for the age.
CONCLUSIONS: The frequency of influenza B Victoria and Yamagata infection is age dependent with no significant differences detected in clinical presentation comparing both lineages.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age distribution; Clinical presentation; Influenza B; Victoria lineage; Yamagata lineage

Mesh:

Year:  2014        PMID: 25034374     DOI: 10.1016/j.jcv.2014.06.018

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  27 in total

1.  Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Authors:  Andrea Orsi; Giuseppina Maria Elena Colomba; Fanny Pojero; Giuseppe Calamusa; Cristiano Alicino; Cecilia Trucchi; Paola Canepa; Filippo Ansaldi; Francesco Vitale; Fabio Tramuto
Journal:  Hum Vaccin Immunother       Date:  2017-08-03       Impact factor: 3.452

Review 2.  Influenza B: Prospects for the Development of Cross-Protective Vaccines.

Authors:  Liudmila M Tsybalova; Liudmila A Stepanova; Edward S Ramsay; Andrey V Vasin
Journal:  Viruses       Date:  2022-06-17       Impact factor: 5.818

3.  Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households.

Authors:  Cuiling Xu; Kwok-Hung Chan; Tim K Tsang; Vicky J Fang; Rita O P Fung; Dennis K M Ip; Simon Cauchemez; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2015-09-22       Impact factor: 4.897

4.  Epidemiological and Clinical Characteristics of Influenza Outbreaks Among Children in Chongqing, China.

Authors:  Xuchen Meng; Han Zhao; Rong Ou; Qing Zeng; Huiqun Lv; Hua Zhu; Mengliang Ye
Journal:  Front Public Health       Date:  2022-04-15

5.  Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014.

Authors:  Xiang Yong Oong; Kim Tien Ng; Tommy Tsan-Yuk Lam; Yong Kek Pang; Kok Gan Chan; Nik Sherina Hanafi; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

6.  The contrasting phylodynamics of human influenza B viruses.

Authors:  Dhanasekaran Vijaykrishna; Edward C Holmes; Udayan Joseph; Mathieu Fourment; Yvonne C F Su; Rebecca Halpin; Raphael T C Lee; Yi-Mo Deng; Vithiagaran Gunalan; Xudong Lin; Timothy B Stockwell; Nadia B Fedorova; Bin Zhou; Natalie Spirason; Denise Kühnert; Veronika Bošková; Tanja Stadler; Anna-Maria Costa; Dominic E Dwyer; Q Sue Huang; Lance C Jennings; William Rawlinson; Sheena G Sullivan; Aeron C Hurt; Sebastian Maurer-Stroh; David E Wentworth; Gavin J D Smith; Ian G Barr
Journal:  Elife       Date:  2015-01-16       Impact factor: 8.140

7.  Epidemiological, Clinical and Virological Characteristics of Influenza B Virus from Patients at the Hospital Tertiary Care Units in Bangkok during 2011-2014.

Authors:  Navin Horthongkham; Niracha Athipanyasilp; Archiraya Pattama; Bualan Kaewnapan; Suthatta Sornprasert; Surangrat Srisurapanont; Wannee Kantakamalakul; Palanee Amaranond; Ruengpung Sutthent
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

8.  Epidemiological and Virological Characterization of Influenza B Virus Infections.

Authors:  Sivan Sharabi; Yaron Drori; Michal Micheli; Nehemya Friedman; Sara Orzitzer; Ravit Bassal; Aharona Glatman-Freedman; Tamar Shohat; Ella Mendelson; Musa Hindiyeh; Michal Mandelboim
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

9.  Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases.

Authors:  Marcos C Vieira; Celeste M Donato; Philip Arevalo; Guus F Rimmelzwaan; Timothy Wood; Liza Lopez; Q Sue Huang; Vijaykrishna Dhanasekaran; Katia Koelle; Sarah Cobey
Journal:  Nat Commun       Date:  2021-07-14       Impact factor: 14.919

10.  Epidemiological and Phylogenetic Characteristics of Influenza B Infection in Severe Acute Respiratory Infection Cases in Beijing, 2014 to 2015.

Authors:  Yang Pan; Yi Zhang; Peng Yang; Haiqun Qian; Weixian Shi; Shuangsheng Wu; Shujuan Cui; Daitao Zhang; Quanyi Wang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.